Pancreatic Cancer Research

ResearcherSt. Jude Children's Research HospitalActive in the last 2 years

Damianos S. Skopelitis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4724-5462; OpenAlex author ID A5040391300; NIH RePORTER profile ID 77898563. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
2
Collaborators
12
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 grant

Papers 2

  1. KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. Co-author DOI 10.1038/s41467-025-66007-0↗
  2. Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41588-024-01790-y↗

Grants 1

  1. Genetic technology development for elucidating lineage plasticity mechanisms in cancer R50CA305054↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher R. Vakoc · 2 shared papers, 2024–2025 · strength 0.43
  2. Mikala Egeblad · 2 shared papers, 2024–2025 · strength 0.43
  3. Diogo Maia-Silva · 2 shared papers, 2024–2025 · strength 0.43
  4. Patrick Cunniff · 2 shared papers, 2024–2025 · strength 0.43
  5. Nicole Sivetz · 1 shared paper, 2025 · strength 0.27
  6. Camila dos Santos · 1 shared paper, 2024 · strength 0.16
  7. David L Spector · 1 shared paper, 2024 · strength 0.16
  8. Ledong Wan · 1 shared paper, 2024 · strength 0.16
  9. Yunus Sahin · 1 shared paper, 2024 · strength 0.16
  10. Douglas T. Fearon · 1 shared paper, 2024 · strength 0.16
  11. Philip Moresco · 1 shared paper, 2024 · strength 0.16
  12. Adrian R. Krainer · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.